Skip to main content
. 2018 Mar 4;23(2):e12474. doi: 10.1111/hel.12474

Table 2.

Review of the literature on efficacy of Helicobacter pylori eradication for H. pylori‐positive gastric MALT lymphoma: Retrospective studies

Author (year)Ref. All patients Stage I Stage II1 Median follow‐up (months) Relapse (%) Treatment failurea (%)
No . CR cases (%) No. CR cases (%) No. CR cases (%)
Pinotti (1997)26 49 30 (61) 49 30 (61) 0 22 2 (6.6) 5 (10)
Savio (2000)27 76 71 (93) 75 71 (95) 1 0 28 6 (8.5) 6 (7.9)
Wündisch (2006)20 196 146 (75) 193 146 (76) 0 27 5 (3.4) 18 (9.2)
Nakamura (2008)28 70 55 (79) 65 54 (83) 5 1 (20) 46 1 (1.8) 10 (14)
Stathis (2009)21 85 66 (78) 80 66 (83) 5 0 76 16 (24) 23 (27)
Andriani (2009)29 60 42 (70) 44 37 (84) 9 5 (56) 65 13 (31) 16 (27)
Ono (2010)12 50 48 (96) 43 42 (98) 7 6 (86) 76 0 2 (4.0)
Nakamura (2012)15 376 317 (84) 378 304 (80) 35 17 (49) 72 10 (3.2) 37 (9.8)
Moleiro (2016)22 93 77 (83) 82 73 (89) 11 4 (36) 109 11 (14) 27 (29)
Total 1055 852 (81) 1009 823 (82) 73 33 (45) 65 64 (7.5) 144 (14)

CR, complete remission.

a

Relapse, progressive disease, and/or non‐CR at 6 months after eradication.